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Abstract
Summary Peripheral quantitative computed tomography
scans of the distal and midshaft radius were performed in
514 European men aged 40–79 years at baseline and a median
of 4.3 years later. Age-related changes in volumetric bone
mineral density (vBMD) and bone geometry were greater in
men with higher biochemical markers of bone turnover at
baseline.
Introduction This study aimed to determine prospective
change in bone density and geometry at the radius in
men and examine the influence of bone turnover markers
and sex hormones on that change.
Methods Men aged 40–79 years were recruited from popula-
tion registers in Manchester (UK) and Leuven (Belgium). At
baseline, markers of bone formation (P1NP and osteocalcin)
and resorption (β-cTX and ICTP) were assessed. Total and
bioavailable testosterone and oestradiol were also measured.
Peripheral quantitative computed tomography (pQCT) was
used to scan the radius at distal and midshaft sites at the base-
line assessment and a median of 4.3 years later.
Results Five hundred fourteen men, mean (SD) age of 59.6
(10.5) years, contributed to the data. At the midshaft site, there
was a significant decrease in mean cortical vBMD (−0.04 %/
year), bone mineral content (BMC) (−0.1 %/year) and cortical
thickness (−0.4 %/year), while total and medullary area in-
creased (+0.5 and +2.4 %/year respectively). At the distal
radius, total vBMD declined (−0.5 %/year) and radial area
increased (+0.6 %/year). Greater plasma concentrations of
bone resorption and formation markers were associated with
greater decline in BMC and cortical area at the midshaft and
total vBMD at the distal site. Increased bone resorption was
linked with an increase in total and medullary area and de-
crease in cortical thickness at the midshaft. Sex hormone
levels were unrelated to change in pQCT parameters.
Conclusions Age-related changes in vBMD and bone geom-
etry are greater in men with higher biochemical markers of
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bone turnover at baseline. Sex hormones have little influence
on change in pQCT parameters.
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Introduction
Osteoporosis in men is a considerable public health prob-
lem with the lifetime risk of fracture in men after age
50 years estimated at ~20 % [1]. Most studies examining
changes in bone health with age have focussed on ‘areal’
bone mineral density (aBMD; g/cm2) [2] as measured by
dual-energy X-ray absorptiometry (DXA) [3–8].
However, bone strength is influenced not only by bone
mineral content but also by bone shape and mineral dis-
tribution and the loading conditions to which the bone is
subjected. In addition, DXA tends to overestimate aBMD
in larger, and underestimate in smaller, bones [9].
Peripheral quantitative computed tomography (pQCT) al-
lows assessment of both bone geometry and volumetric
BMD (vBMD). Data from cross-sectional studies, includ-
ing data from the European Male Ageing Study (EMAS),
suggest variously a lower distal radius vBMD and bone
mineral content (BMC), thinner cortices and greater cross-
sectional bone area with increasing age [10–17].
However, there are limitations to estimating true longitu-
dinal change in bone parameters from cross-sectional da-
ta. In contrast to our understanding about prospective
change in DXA aBMD, there are relatively few data
concerning prospective change in pQCT parameters in
middle-aged and elderly men [18–20], with few data on
change in bone geometry at the midshaft and distal radius.
In older men, cross-sectional studies suggest that increased
bone turnover markers are associated with lower aBMD [21,
22] and, more recently, microarchitectural parameters [23]. In
line with these findings, prospective data suggest that higher
levels of bone remodelling may be associated with increased
rates of bone loss [24, 25]; however, there are no data linking
bone turnover markers to changes in bone geometry in older
men.
Levels of sex steroids are known to be associated with
aBMD in men, as assessed using DXA, and also rate of
bone loss [7, 21, 26–32]. The contribution of oestradiol
(E2) to BMD has been reasonably well established, but
the effect of testosterone (T) is less clear as are the effects
of sex hormones on bone structural parameters [33].
Khosla et al. [16] showed that E2 was the most constant
predictor of BMD and some geometrical variables,
assessed by QCT, and similarly in the MINOS cohort, E2
was related to aBMD and cortical thickness [26]. Using
data from the baseline EMAS survey, we showed a weak
association between vBMD and E2, while the association
of T with bone geometry was inconsistent [17].
The aims of this prospective study were firstly, to charac-
terise longitudinal changes in bone density and structure at the
radius in middle-aged and elderly European men; secondly, to
determine the relationship between bone turnover markers and
subsequent change in BMD and bone structure; and thirdly, to
determine the association between sex hormones and change
in BMD and structure.
Materials and methods
Subjects
The subjects included in this analysis were recruited for par-
ticipation in the EMAS, a prospective study of ageing in
European community-dwelling men. Detailed methods have
been described previously [34]. Briefly, men were recruited
from population-based sampling frames in eight centres be-
tween 2003 and 2005. Stratified random sampling was used
with the aim of recruiting equal number of men in each of four
10-year age bands: 40–49, 50–59, 60–69 and 70–79 years.
Letters of invitation were sent to subjects asking them to at-
tend for health assessments by a range of health question-
naires, physical performance tests, anthropometry and a
fasting blood sample. In two centres, Manchester (UK) and
Leuven (Belgium), subjects had pQCT measurements per-
formed at the radius. The men were invited to participate in
a follow-up assessment in a median of 4.3 years later. Ethics
approval for the study was obtained in accordance with local
institutional requirements in each centre, and each participant
gave written informed consent.
Peripheral pQCT
Peripheral QCT measurements of the non-dominant radius
were made in men recruited to the Manchester and Leuven
centres at both baseline and follow-up using XCT-2000
scanners (Stratec, Pforzheim, Germany). At the distal
(4 %) site, total and trabecular vBMD (mg/cm3) and bone
cross-sectional area (mm2) were measured (voxel size
0.4 mm); the slice location at the 4 and 50 % sites was
more distal in Leuven compared to Manchester; the refer-
ence line was placed at the distal border of the radial end
plate in Leuven, and in Manchester, the line was placed to
bisect the lateral border of the end plate. These differences
resulted in a scan site difference of approximately 1–2 mm
between the centres. At the diaphysis (50 % site, voxel size
0.6 mm), cortical vBMD (mg/cm3); BMC (mg/mm); total,
cortical and medullary areas (mm2); cortical thickness
(mm); and stress strain index ((SSI) mm3) were measured.
SSI provides a measure of a bone’s torsional strength [35,
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36]. A detailed methodology for these measurements has
been described previously [37].
For cross-calibration between Leuven and Manchester, the
European forearm phantom (EFP) was measured [38]. There
were no differences greater than precision error for trabecular,
total and cortical BMD, BMC or cortical area, therefore no
cross-calibration was performed between the two centres [17].
The short-term precision of two repeat radius measurements
with repositioning in Manchester (n=22) and Leuven (n=40),
respectively were as follows: trabecular BMD 1.27 and
1.42 %; total BMD 2.1 and 1.3 %; cortical BMD 0.77 and
0.71 %; and cortical area 2.4 and 1.3 %. The manufacturer’s
standard quality assurance procedures were followed in both
centres.
Bone marker measurement
Bone turnover markers were measured at baseline on the
Elecsys 2010 automated analyser (Roche Diagnostics
GmbH, Mannheim, Germany). To assess bone resorption, se-
rum beta C-telopeptide of type I collagen (β-cTX) was mea-
sured at baseline using the ß-Crosslaps/serum reagents [39].
This assay is specific for cross-linked ß-isomerised type I col-
lagen C-telopeptide fragments and uses two monoclonal anti-
bodies, each recognising the Glu-Lys-Ala-His-ßAsp-Gly-Gly-
Arg peptide (Crosslap antigen). The intra-assay coefficient of
variation (CV) evaluated by repeated measurements of several
serum samples was <5.0 %. The detection limit was 10 pg/
mL. Carboxyterminal telopeptide region of type I collagen
(ICTP) was measured using the competitive radioimmunoas-
say technique. A known amount of labelled ICTP and an
unknown amount of unlabelled ICTP in the sample compete
for the limited number of high-affinity binding sites of the
antibody. After separating the free antigen, the amount of la-
belled ICTP in the sample tube is inversely proportional to the
amount of ICTP in the sample. The concentrations in the un-
known samples are obtained from a calibration curve. The
intra-assay CV was <9 %, and the lower detection limit was
<0.4 μg/L. To evaluate bone formation, measurements were
performed on the Elecsys 2010 with a two-site assay using
monoclonal antibodies raised against intact human P1NP pu-
rified from human amniotic fluid. This assay detects both
intact monomeric and trimeric forms (total P1NP), as previ-
ously described [40]. The intra-assay CV was <3.0 %, and the
lower detection limit was <5 ng/mL. The Elecsys N-MID
osteocalcin assay uses two monoclonal antibodies specifically
directed against epitopes on the N-MID fragment as well as
the intact osteocalcin. The test is non-dependent on the unsta-
ble C-terminal fragment of the osteocalcin molecule and thus
ensures constant measurement results under routine condi-
tions in the laboratory. The intra-assay CV was <4 %, and
the lower detection limit was <0.5 ng/mL.
Sex hormone measurement
A single fasting morning (before 10.00 h) venous blood
sample was obtained from all subjects at the baseline as-
sessment. Serum was separated immediately after phlebot-
omy and stored at −80 °C until assay at the end of the
baseline study. Measurement of T and E2 was carried out
by gas chromatography-mass spectrometry (GC-MS) as
described in Labrie et al. [41, 42]. The lower limit of T
quantitation was 0.17 nmol/L and of E2 was 7.34 pmol/L.
The coefficients of variation of T measurements were
2.9 % within runs and 3.4 % between runs and for E2 were
3.5 % within runs and 3.7 % between runs. Sex hormone-
binding globulin (SHBG) was measured by the Modular
E170 platform electrochemiluminescence immunoassay
(Roche Diagnostics, Mannheim, Germany) as previously
described [43]. Free and bio T and E2 levels were derived
from total T, total E2, SHBG and albumin concentrations
using mass action equations and association constants of
Vermeulen et al. and Van Pottelbergh et al. [29, 44].
Statistical analysis
Descriptive statistics were used to summarise subject charac-
teristics at baseline. The change in pQCT parameters was
calculated as percentage change per year ((follow-up
value − baseline value) / baseline value × 100 / time between
scans). Differences between baseline and follow-up pQCT
parameters were assessed using paired t tests. Linear regres-
sion analysis was used to investigate the association of change
in pQCT parameters with markers of bone turnover
(osteocalcin, P1NP and ICTP and B-cTX) and sex hormones
including total and bioavailable E2 and T. In the linear regres-
sion analyses, bone turnover markers and sex hormones were
standardised (Z-score), so the results represent the change in
pQCT parameters per standard deviation increase in the inde-
pendent variable. Adjustments were made in these analyses
for age, height, weight and centre, and the results were
expressed as standardised (Z-score) β coefficients and 95 %
confidence intervals (CIs). Statistical analysis was performed
using Stata version 13 (StataCorp, College Station, TX).
Results
Subject characteristics
Five hundred forty men had baseline and follow-up assess-
ments. Of these, 26 were excluded because of therapy which
may have impacted on bone including sex hormones,
antiosteoporotic therapies and glucocorticoids. Of the 514 in-
cluded in the analysis, the mean (standard deviation) age was
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59.6 (10.5) years and the mean (standard deviation) BMI was
27.3 (3.8) kg/m2, see Table 1.
Change in bone mass and geometry
There was significant change in most pQCT parameters
over the course of the study, see Table 2. At the midshaft
radius, mean cortical BMC and vBMD decreased by −0.1
(P = 0.03) and −0.04 % (P = 0.007) per year respectively,
while the medullary and total area increased by 2.4 %
(P = 0.0001) per year and 0.5 % (P = 0.0001) per year
respectively. Cortical thickness declined by 0.4 %
(P < 0.001) per year, with no significant change in cortical
area or SSI. At the distal radial site, there was a significant
reduction in total vBMD (0.5 % per year, P < 0.0001)
while radial area increased (0.6 % per year, P < 0.0001).
In this sample of men age 40–79 years, there was no asso-
ciation between the age and the rate of change of the pQCT
parameters (data not shown).
Influence of bone turnover on change in pQCT
parameters
Midshaft
After adjustment for age, height, weight and centre, an in-
crease in bone resorption markers (ICTP and β-cTX) as well
as bone formation markers (PINP and osteocalcin) were asso-
ciated with a significant reduction in cortical BMC, see
Table 3. An increase in ICTP was associated with a significant
increase in both total area (β per SD change = 0.25 % per
year) and medullary area (β per SD change = 0.93 % per
year). Markers of bone resorption (β-cTX and ICTP) were
associated with a greater decline in cortical thickness in the
adjusted model. P1NP, osteocalcin and β-cTX were associat-
ed with a greater decline in cortical area, see Table 3.
Distal radius
After adjustment for age, height, weight and centre, an in-
crease in β-cTX and P1NP was associated with a reduction
in total vBMD (β per SD change = −0.14 and −0.16 % per
year respectively). β-cTX was also associated with a reduc-
tion in trabecular vBMD (β per SD change = −0.13 % per
year).
Influence of sex hormones on change pQCT parameters
The association between free and bioavailable fractions of T
and E2 with pQCT parameters was broadly similar, so here we
present data for the total and bioavailable hormone relation-
ships (bioE2, bioT), see Table 4. There was no association
between bio T and E2 nor SHBG (data not shown) on change
in any of the pQCT parameters in the adjusted models.
Discussion
Our data show evidence in middle-aged and elderly men of a
longitudinal change in bone mass and geometry at the radial
midshaft with a decline in cortical vBMD, BMC and cortical
thickness and an increase in medullary and total area. At the
distal radius site, there was a decline in the total volumetric
BMD and an increase in radial area. A higher rate of bone
turnover at baseline (formation and resorption) was associated
with a greater reduction in cortical BMC and cortical area at
the midshaft and total vBMD at the distal radius. Increased
resorption markers were associated with an increase in total
and medullary area, a decrease in cortical thickness at the
midshaft and a greater rate of decline in trabecular vBMD at
the distal radius. In contrast, sex hormones, within the normal
range in our community-dwelling sample of men, appeared to
have little influence on the change in vBMD and geometry as
measured by pQCT.
A number of cross-sectional studies have looked at the
influence of age on pQCT parameters in men [10–17]. In a
cross-sectional study of 202 men aged 20–99 years and using
a high-resolution pQCT, trabecular area/height at the radius
increased with age by 28 %, while other parameters decreased
with increasing age, including trabecular BMD (−32 %), tra-
becular thickness (−16 %), cortical area/height (−5 %), corti-
cal BMD ( −15 %) and cortical thickness (−21 %) [11]. In
Table 1 Subject characteristics
Mean (SD)
Age at interview (years) 59.6 (10.5)
Height (cm) 174.9 (7.1)
Weight (kg) 83.5 (13.2)
Body mass index (kg/m2) 27.3 (3.8)
Testosterone (nmol/L) 18.2 (6.0)
Free testosterone (pmol/L) 320.0 (87.1)
Bioavailable testosterone (nmol/L) 8.0 (2.3)
Oestradiol (pmol/L) 77.8 (24.9)
Free oestradiol (pmol/L) 1.3 (0.4)
Bioavailable oestradiol (pmol/L) 54.6 (17.5)
SHBG (nmol/L) 42.8 (18.4)
P1NP (ng/mL) 42.7 (20.3)
Osteocalcin (ng/mL) 22.3 (7.9)
β-cTX (pg/mL) 327.5 (155.6)
ICTP (ng/mL) 3.1 (0.9)
SD standard deviation, SHBG sex hormone-binding globulin, P1NP se-
rum N-terminal propeptide of type 1 procollagen, β-cTX β-C-terminal
cross-linked telopeptide, ICTP carboxyterminal telopeptide of type I
collagen
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another cross-sectional study using high-resolution pQCT
(HR-pQCT) of men aged 20–80 years, compared to younger
men (≤35 years), older men (mean age 80 years) had larger
total area, thinner trabeculae and lower total and trabecular
BMD at the radius [10]. There are, however, limitations in
interpreting these data given their cross-sectional design
[18]. There are few prospective studies which have looked at
change in bonemass and geometry. Data from the Gothenburg
Osteoporosis and Obesity Study [45] showed change in radial
pQCT parameters in younger men, around the time of accrual
of peak bone mass; however, there are limited data in older
men (over 60 years of age). In a 7.5 year prospective study,
Specker et al. described rates of change at the 4 and 20 %
distal radial sites in three distinct populations of 20–66-year-
old men [20]. There were increases in bone cross-sectional
area, cortical thinning and decreasing bone strength (at older
ages) during follow-up. In the InChianti study [18], Lauretani
et al., using tibial pQCT data in 345 men (age 21–101 years),
reported a decline in BMD and an increase in medullary and
total bone area. In a study using HR-pQCT, Shanbhogue et al.
reported an increase in trabecular vBMD at the distal radius in
men aged 50 years and older over a median follow-up of
3 years, with no significant change in total vBMD or cortical
area though the number of men who were studied was rela-
tively small (88) [46].
Given the paucity of prospective data concerning change in
pQCT, it is not surprising that there are few data which have
looked at the link between bone turnover markers and bone
structural change at the distal radius. Using data from the
GOOD study, Darelid et al. reported that osteocalcin (OC)
was a positive predictor of an increase in aBMD and BMC
at the radius between the ages of 19 and 24 years; also, men in
the highest quartile of OC at baseline were more likely to gain
in radial cross-sectional area and trabecular vBMD than men
in the lowest quartile [47]. These findings, particularly in re-
lation to BMD differ from our findings; however, this almost
certainly reflects the fact the GOOD study focused on a much
younger cohort of men. Our results suggest that increased
turnover, and particularly bone resorption, is linkedwith struc-
tural decay and vBMD loss in older men. Such increased bone
turnover may be due to a variety of factors including lifestyle,
hormonal and metabolic factors (for example GH-IGF, adre-
nal, sex steroids, PTH, sclerostin and inflammatory status).
While there are some similarities to bone loss in women, it
is important to recognise there is a sexual dimorphism in pat-
terns of bone ageing. It seems plausible that the reduction in
cortical thickness from endosteal bone resorption would im-
pair bone strength if increased strains did not lead to compen-
satory periosteal expansion to redistribute the bone over a
larger cross-sectional area as a mechanism to maintain bone
strength. We observed no overall change in stress strain index,
suggesting that biomechanical stability persisted despite the
loss in cortical thickness. Redistribution of bone is due to
periosteal apposition (indicated by an increase in bone area),
and our data are in line with previous studies, suggesting that
periosteal bone formation in old age may largely be driven in
response to endosteal resorption [33]. In any case, the main-
tenance of bone strength via this mechanism may be one rea-
son why the incidence of wrist fracture in men, in contrast to
women, remains low until latter life, though further studies are
needed [1, 15].
There is some evidence, at least inmice and rats, that Tmay
increase periosteal apposition (and thereby increase total ar-
ea), and certainly in adolescents, T increases periosteal growth
[33]. Szulc et al. using DXA data suggested an increase in
periosteal apposition with age, though not via an action of T
[26]. In contrast, Khosla et al. found an inverse association in
men with higher levels of T linked with reduced bone area
Table 2 Radial pQCT parameters: baseline and follow-up
Mean (SD) value at baseline Mean (SD) value at follow-up Mean (SD) % change per year P valuea
Midshaft radius
Cortical vBMD (mg/cm3) 1214.6 (29.9) 1212.7 (30.1) −0.04 (0.3) 0.007
Cortical BMC (mg/mm) 124.0 (17.3) 123.5 (17.6) −0.1 (1.3) 0.03
Total area (mm2) 150.3 (21.6) 152.5 (21.1) 0.5 (2.1) 0.0001
Cortical area (mm2) 107.5 (13.9) 107.3 (14.1) −0.06 (1.2) 0.18
Cortical thickness (mm) 3.3 (0.4) 3.2 (0.4) −0.4 (2.3) <0.0001
Medullary area (mm2) 42.7 (17.0) 45.2 (17.2) 2.4 (6.7) 0.0001
Stress strain index (mm3) 342.9 (66.5) 341.5 (64.1) −0.006 (1.8) 0.3
Distal radius
Total vBMD (mg/cm3) 398.7 (73.2) 391.6 (73.6) −0.5 (1.4) <0.0001
Radial area (mm2) 381.1 (68.0) 387.8 (69.9) 0.6 (2.5) <0.0001
Trabecular vBMD (mg/cm3) 207.1 (42.3) 206.7 (41.8) −0.02 (1.4) 0.3
SD standard deviation, BMD bone mineral density (mg/cm3 ), BMC bone mineral content (mg/mm), vBMD volumetric bone mineral density
aP value for difference between baseline and follow-up value using a paired t test
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[16]. Our results, however, showed no significant association
between either testosterone or oestrogen and change in bone
geometry, suggesting that these are not the primary drivers of
structural bone decay in community-dwelling men. Evidence
from observational and clinical studies support the view that
oestrogen is the most important sex steroid in determining
bone mass in men [7, 21, 27, 29, 32], with some evidence of
a threshold effect, though studies so far are inconclusive [16,
48]. All but eight men in our cohort had total E2 >37 pmol/L.
Given the low prevalence of clinically significant
hypogonadism in EMAS, however, the study may have been
underpowered to examine associations between sex steroids
and longitudinal pQCT changes.
The strengths of our study were the population sample and
the prospective design. There are, however, some limitations
which need to be consideredwhen interpreting the results. The
response rates for participation in the baseline survey in
Manchester and Leuven were 38.8 and 38.6 % respectively
[34]. It is possible that those who did not take part may have
differed with respect to their pQCT measurements and also
bone turnover markers and also sex steroid levels resulting in
an overestimation or underestimation with respect to the true
population value, and so caution is required in interpreting the
absolute levels of these measurements. However, the main
findings, in relation to the relationship between bone turnover
markers and sex steroid levels and change in pQCT parame-
ters, were based on internal comparisons among responders
and so selection factors are unlikely to have influenced the
strength of the observed biological relationships.
One of the key factors in designing the study was to ensure
standardisation of the study instruments used in the different
participating centres. Hormone and bone turnover marker
measurements were performed in a central reference laborato-
ry to minimise assay variability, and gold standard mass spec-
trometry methods were applied. The same pQCTscanner type
and model was used in each centre, and after testing scanner
differences with the EFP, no cross-calibration was necessary.
In our analysis, with 10 bone parameters, it is possible that a
number of the significant findings may have been due to
chance. The analysis was, however, based on an a priori hy-
pothesis that bone turnover markers and sex hormones may
impact on bone, and setting more conservative thresholds for
significance may have increased the likelihood of missing true
biological associations. Finally, the data were derived from a
European Caucasian population and so the results may not
necessarily be extrapolated beyond this setting.
In conclusion, our study provides the first longitudinal
characterisation of the gradual BMD and bone geometry
changes with age at the radius in middle-aged and elderly
European men. Increased bone turnover in such men is pre-
dictive of bone loss as measured by pQCT. Sex hormones in
the normal range, however, appeared to have no influence on
the change in pQCT parameters.
Compliance with ethical standards Ethics approval for the study was
obtained in accordance with local institutional requirements in each cen-
tre, and each participant gave written informed consent.
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